Veeva Systems Inc. Profile Avatar - Palmy Investing

Veeva Systems Inc.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics so…
Medical - Healthcare Information Services
US, Pleasanton [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -16.44 188.86 226.00
Graham Fair Price 7.23 26.13 24.36
PEG -4.20 5.70 5.95
Price/Book -8.87 6.56 7.19
Price/Cash Flow -93.64 42.45 667.77
Prices/Earnings -12.53 49.57 56.67
Price/Sales -6.98 49.28 52.98
Price/FCF -93.64 42.45 667.77
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 1.98 0.73 0.72
Operating Margin 11.24 0.24 0.21
ROA 4.77 0.03 0.02
ROE 0.03 0.03 4.19
ROIC 0.02 0.02 5.61
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ < 0.005 -0.03 98.25
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ 0.05 0.15 179.13
EPS QOQ 0.10 0.09 -8.70
FCF QOQ -0.35 14.09 3954.08
Revenue QOQ 0.02 0.03 36.65
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 126.81 55.51 -56.23
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.01 0.01 -5.00
Quick Ratio 4.17 4.22 1.27
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 28.83 30.29 5.05
Cash 25.00 29.52 18.06
Capex -0.05 -0.05 -9.35
Free Cash Flow 0.31 4.68 1405.94
Revenue 3.91 4.03 2.92
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 4.24 4.29 1.03
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -4.47 -6.97 -56.09
Naive Interpretation Member
06 - Financial Health · Bad
End of VEEV's Analysis
CIK: 1393052 CUSIP: 922475108 ISIN: US9224751084 LEI: - UEI: -
Secondary Listings